Carlos B. Ros
Bern, BE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Transferrin receptor 1 binds human parvovirus B19 VP1u to facilitate entry.
Journal: Nature communications
Published: March 13, 2026
Cellular determinants of parvovirus B19 susceptibility in the human placenta.
Journal: PLoS pathogens
Published: October 07, 2025
Globoside Is an Essential Intracellular Factor Required for Parvovirus B19 Endosomal Escape.
Journal: Cells
Published: July 02, 2024
Infectious parvovirus B19 circulates in the blood coated with active host protease inhibitors.
Journal: Nature communications
Published: July 02, 2024
Globoside and the mucosal pH mediate parvovirus B19 entry through the epithelial barrier.
Journal: PLoS pathogens
Published: January 18, 2023
A Conserved Receptor-Binding Domain in the VP1u of Primate Erythroparvoviruses Determines the Marked Tropism for Erythroid Cells.
Journal: Viruses
Published: January 11, 2022
Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.
Journal: Orphanet journal of rare diseases
Published: March 12, 2021
The SNAP Trial: 2-Year Results of a Double-Blind Multicenter Randomized Controlled Trial of a Silicon Nitride Versus a PEEK Cage in Patients After Lumbar Fusion Surgery.
Journal: Global spine journal
Published: January 07, 2021
Last Updated: 09/26/2026